Lupus nephritis screening: Difference between revisions

	Lupus nephritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lupus nephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lupus nephritis screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lupus nephritis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lupus nephritis screening
CDC on Lupus nephritis screening
Lupus nephritis screening in the news
Blogs on Lupus nephritis screening
Directions to Hospitals Treating Lupus nephritis
Risk calculators and risk factors for Lupus nephritis screening

Latest revision as of 20:31, 19 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D. [2]

According to the United States Preventive Services Task Force, screening for systemic lupus erythematosus is not recommended.

According to the United States Preventive Services Task Force, screening for systemic lupus erythematosus is not recommended.

@@ Line 2: / Line 2: @@
 {{Lupus nephritis}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}}[[User:Okamal|Omer Kamal, M.D.]] [Mailto:okamal@bidmc.harvard.edu| [2]]
 ==Overview==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+According to the United States Preventive Services Task Force, screening for systemic lupus erythematosus is not recommended.
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==Screening==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+According to the United States Preventive Services Task Force, screening for systemic lupus erythematosus is not recommended.
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-*[Condition 1]
-*[Condition 2]
-*[Condition 3]
 ==References==